ENZYGNOST F 1+2— 510(k) K922934

Substantially Equivalent

Behring Diagnostics, Inc.

FDA 510(k) clearance K922934 for ENZYGNOST F 1+2, Substantially Equivalent on 1992-11-16. Applicant: Behring Diagnostics, Inc..

Clearance details

Applicant
Behring Diagnostics, Inc.
Product code
Code MIF
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Somerville, NJ, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.